Product Program year 2024 Source: CMS Open Payments

Tiglutik

Drug Neurology

NDC 70726-0303-1

Open in the dashboard

General payments

$16,081

120 payments

Research payments

$0

0 payments

Through program year 2024, $16,081 in general payments and $0 in research payments were reported against Tiglutik (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $2,611 20
2021 General $311 4
2020 General $1,142 21
2019 General $12,017 75

Breakdown

Who paid General payments · program years 2019–2024
  1. EDW Pharma, Inc. $16,081 120 payments
Top recipients General payments · program year 2024
  1. Kevin Callerame Neurology · Baton Rouge, LA $352 13% · 1 payment
  2. Aimee Garza Neurology · Frisco, TX $343 13% · 1 payment
  3. Er-Kai Gao Neurological Surgery · La Mesa, CA $331 13% · 1 payment
  4. Christopher Edwards Neurology · Rockport, ME $292 11% · 1 payment
  5. Vahid Tohidi Neurology · Orlando, FL $268 10% · 1 payment

The top 5 of 20 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Neurology Psychiatry & Neurology $1,825 70% · 12 practitioners
  2. Neurological Surgery $331 13% · 1 practitioner
  3. Neuromuscular Medicine Psychiatry & Neurology $242 9% · 2 practitioners
  4. Nurse Practitioner $79 3% · 1 practitioner
  5. Nurse Practitioner, Family Nurse Practitioner $64 2% · 2 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Louisiana $937 36% · 5 recipients
  2. California $353 14% · 2 recipients
  3. Colorado $352 13% · 3 recipients
  4. Florida $348 13% · 2 recipients
  5. Texas $343 13% · 1 recipient

The top 5 of 10 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

120 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record